CUSIP: 03842B101
What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 03842B101:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2019 Q3 | 0 | $0 | -$39,338,972 | 0 | |
| 2019 Q2 | 16,672,269 | $39,345,972 | -$524,138 | $2.36 | 32 |
| 2019 Q1 | 16,868,526 | $45,462,667 | -$2,184,875 | $2.70 | 34 |
| 2018 Q4 | 17,744,402 | $38,330,229 | -$1,895,264 | $2.16 | 33 |
| 2018 Q3 | 18,259,616 | $53,499,000 | +$3,428,801 | $2.93 | 45 |
| 2018 Q2 | 17,356,611 | $45,966,000 | -$56,823,834 | $2.65 | 43 |
| 2018 Q1 | 21,415,191 | $301,530,377 | -$375,535 | $14.08 | 49 |
| 2017 Q4 | 21,492,427 | $252,766,200 | +$3,239,114 | $11.76 | 51 |
| 2017 Q3 | 21,159,380 | $300,247,000 | -$16,315,611 | $14.19 | 43 |
| 2017 Q2 | 22,322,586 | $314,081,000 | -$10,424,555 | $14.07 | 40 |
| 2017 Q1 | 23,041,455 | $384,298,000 | +$19,134,249 | $16.69 | 39 |
| 2016 Q4 | 23,409,871 | $386,429,000 | +$7,870,919 | $16.51 | 48 |
| 2016 Q3 | 22,886,897 | $305,770,000 | +$100,669,785 | $13.36 | 46 |
| 2016 Q2 | 15,385,873 | $101,850,000 | -$5,416,385 | $6.62 | 33 |
| 2016 Q1 | 15,734,762 | $138,776,000 | +$16,549,758 | $8.82 | 35 |
| 2015 Q4 | 13,741,756 | $171,493,000 | -$2,315,306 | $12.48 | 39 |
| 2015 Q3 | 12,974,112 | $182,543,000 | +$134,059,664 | $14.07 | 31 |
| 2015 Q2 | 3,964,735 | $27,516,000 | -$818,439 | $6.94 | 26 |
| 2015 Q1 | 4,079,951 | $34,148,000 | -$718,460 | $8.23 | 24 |
| 2014 Q4 | 4,165,796 | $31,242,000 | +$171,565 | $7.50 | 21 |
| 2014 Q3 | 4,147,927 | $27,627,000 | -$2,168,446 | $6.66 | 22 |
| 2014 Q2 | 4,376,279 | $41,074,000 | -$3,492,531 | $9.38 | 19 |
| 2014 Q1 | 4,678,323 | $59,557,000 | +$59,398,000 | $12.73 | 23 |